PS377 Unit 4 HIV and Health Paper Example

Two Pill Bottles and One Bus Route: A PS377 Unit 4 HIV and Health Paper

[Student Name]

Purdue University Global

PS377: Models of Peer Recovery

Unit 4 HIV and Health Paper

[Instructor Name]

[Date]

The writer, the center, the participant and every detail are composite and illustrative; the articles cited are real.

Tasha's Health Picture

Tasha, thirty-one, started methadone three months ago and learned two years ago that she has HIV. She likely acquired HIV through shared injection equipment during the years she injected heroin and later fentanyl. In the week of her first visit to the center, her HIV clinic had told her that her viral load, the amount of virus in her blood, had risen from undetectable to detectable after she missed nine days of her antiretroviral medication in one month.

She told me why. Her methadone clinic opens at 6:00 a.m., her HIV pills were at home across town, and on mornings when she stayed at her cousin's house, she had her methadone but not her HIV medication. "It's not that I don't care," she said. "It's that they live in two different places."

How Substance Use and HIV Interact

Altice et al. (2010) reviewed the medical, psychiatric and substance use conditions that commonly occur together among people living with HIV who use drugs. They described how active drug use, mental illness, unstable housing and other medical conditions make it harder to start and stay on antiretroviral therapy, and how stigma and fragmented services add barriers. They argued that integrated care, in which addiction treatment, mental health care and HIV care are coordinated or delivered together, improves outcomes, and that treating opioid dependence is itself part of effective HIV care.

Evidence for Treating Both

Low et al. (2016) pooled studies on whether methadone, buprenorphine and similar treatments change HIV care for people who inject drugs. Receiving opioid substitution therapy was associated with better outcomes across several measures: more people were on antiretroviral therapy, adherence was higher, viral suppression was more common and fewer people dropped out of HIV care.

That evidence matters for Tasha in two ways. Her methadone treatment is not only addiction care; it supports her HIV care. And the link between the two could be made stronger by making them work together in her daily routine.

Her methadone and her HIV pills worked best together, and they lived on opposite sides of town.

What I Did

My role as a peer is practical support, not medical advice. With Tasha's consent, I took four steps.

First, I asked her HIV clinic nurse, with Tasha present, whether the clinic could give her a small weekly pill organizer and a second bottle to keep at her cousin's house. The nurse agreed and also suggested taking the HIV medication at the same time as her methadone dose each morning, which Tasha now does from a small case in her bag.

Second, I helped Tasha set two phone alarms and write her doses on the same paper calendar we use for appointments.

Third, I asked whether her two clinics could communicate. With her signed consent, her methadone counselor and HIV nurse now share a short monthly update, and the methadone clinic knows to remind her if her HIV refill is due.

Fourth, I offered to go with her to her next HIV appointment, which she accepted. She said she had felt judged at the clinic before, and having someone with her made it easier to ask questions.

Other Health Needs

HIV was not Tasha's only health concern. Years of injection had left her with scarred veins and a history of skin infections, she had not seen a dentist in five years, and no one had ever checked her for hepatitis C, which is common among people who have injected drugs. Altice and colleagues describe this pattern: people who use drugs and live with HIV often carry several medical conditions at once, and each one competes for time, money and attention. With Tasha, we made a short list in order of her own priorities. She chose hepatitis C testing first, because her HIV nurse could order it at her next visit, then the dentist, because a broken tooth was keeping her awake. The center keeps a list of clinics that accept her insurance and see patients on methadone without judgment, which saved her from cold-calling offices that might turn her away. Her hepatitis C test came back negative, which she called "the first good news in a long time."

Stigma

Tasha described two kinds of stigma, one about drug use and one about HIV, and said each made the other worse. At her methadone clinic she had not told anyone about her HIV, and at her HIV clinic she felt her drug use made staff assume she would not take her medication. Peers can help here partly by being open about their own experience. I do not have HIV, but I could tell Tasha that I had also felt treated as a problem rather than a patient, and that asking direct questions had helped me.

Testing and Prevention for Others

Peer services reach people that clinics often miss. Eddie et al. (2019) describe linking people to care as one of the main things peers do, and HIV testing is one of the most important links.

Part of peer work around HIV is helping people who do not yet know their status. Our center offers free rapid HIV and hepatitis C testing on Thursdays, and peers encourage anyone who has injected drugs or shared equipment to test. For people who are HIV-negative and at ongoing risk, peers can explain where to learn about prevention medication and refer them to a clinic. We also distribute sterile supplies and naloxone through the local health department's program.

Limits of the Peer Role

I do not interpret lab results, recommend medications or advise on side effects. When Tasha asked whether she could skip a dose on days she felt sick, I helped her call her nurse. My role is to make the medical advice easier to follow, not to give it.

Results

Three months after we started, Tasha had missed one dose of her HIV medication in the previous month, and her latest viral load was undetectable again. She now carries her methadone take-home schedule and her HIV pill case in the same bag.

Conclusion

Tasha's HIV care was disrupted by an ordinary problem: her two medications lived in two places. Altice and colleagues explain how substance use, mental health and HIV care interact and why integration matters, and Low and colleagues show that opioid substitution therapy improves HIV outcomes. Practical, consent-based coordination helped her viral load return to undetectable.

References

Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367-387. https://doi.org/10.1016/S0140-6736(10)60829-X

Eddie, D., Hoffman, L., Vilsaint, C., Abry, A., Bergman, B., Hoeppner, B., Weinstein, C., & Kelly, J. F. (2019). Lived experience in new models of care for substance use disorder: A systematic review of peer recovery support services and recovery coaching. Frontiers in Psychology, 10, Article 1052. https://doi.org/10.3389/fpsyg.2019.01052

Low, A. J., Mburu, G., Welton, N. J., May, M. T., Davies, C. F., French, C., Turner, K. M., Looker, K. J., Christensen, H., McLean, S., Rhodes, T., Platt, L., Hickman, M., Guise, A., & Vickerman, P. (2016). Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis. Clinical Infectious Diseases, 63(8), 1094-1104. https://doi.org/10.1093/cid/ciw416